Kolehump, you are right that one is twenty pass muster, but few drugs come into trials with long and safe OTC history. The key here is its simplicity as a drug and it's unique formulation. As a physician, with one sone a physician, a daughter in law a physician, a brother who is a biochemist at an Ivy Medical School and another son who is a CEO of a major Hospital, please note that they all own Keryx and bought it because they understand Zerenex, have spoken to nephrologists and think that this drug may be a winner have off label applications, and have no real harmful effects other than darkened stools of which I suspect you may be one.
I just can't believe how big an idiot you keep making yourself out to be. The statistics you're pointing out are for NEW drugs that have successful P2 trials and have to progress into P3. Zerenex doesn't fall into that category as it has already passed through a full P3 trial with FLYING COLORS and has a pending NDA for a patient population in much worse health. Just give up kole---everyone on this board knows how desperate you are, both forf attention and to save your hide. How's that chinese telecom short going? How much did you lose?
Sentiment: Strong Buy
.7 increase in Hmg? LOL Don't hang your hat on this. So, If I have a Hmg of 9 and I take this, I lower my phos but only increase .7 of Hmg to a 9.7? I am not above 10. As a patient do I want to wait for an increase of .7. It may lower Procrit or aranesp, but I am taking a shot every 2 weeks or once a month to get my hmg to 10.5 or 11. AND I AM feeling good! They want this claim because they know patients with CKD 2-4 don't have a high phos. You need to add patients to really make this a block buster. This is in CKD 2-4 not CKD 5, which is ESRD. This product will make some money but the cheaper binders will win out in the Obama care.